An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting
Open Access
- 31 October 2012
- journal article
- Published by Springer Science and Business Media LLC in Virology Journal
- Vol. 9 (1), 253
- https://doi.org/10.1186/1743-422x-9-253
Abstract
Background Virus neutralizing antibodies against respiratory syncytial virus (RSV) are considered important correlates of protection for vaccine evaluation. The established plaque reduction assay is time consuming, labor intensive and highly variable. Methods Here, a neutralization assay based on a modified RSV strain expressing the green fluorescent protein in combination with automated detection and quantification of plaques is described. Results The fluorescence plaque reduction assay in microplate format requires only two days to complete and is simple and reproducible. A good correlation between visual and automated counting methods to determine RSV neutralizing serum antibody titers was observed. Conclusions The developed virus neutralization assay is suitable for high-throughput testing and can be used for both animal studies and (large scale) vaccine clinical trials.Keywords
This publication has 18 references indexed in Scilit:
- A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurateJournal of Immunological Methods, 2010
- A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton ratsVirology Journal, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibodyBiologicals, 2007
- An improved plaque reduction virus neutralization assay for human metapneumovirusJournal of Virological Methods, 2007
- Neutralization Assay Using a Modified Vaccinia Virus Ankara Vector Expressing the Green Fluorescent Protein Is a High-Throughput Method To Monitor the Humoral Immune Response against Vaccinia VirusClinical and Vaccine Immunology, 2004
- Role of complement in neutralization of respiratory syncytial virusJournal of Medical Virology, 2004
- Effects of Altering the Transcription Termination Signals of Respiratory Syncytial Virus on Viral Gene Expression and Growth In Vitro and In VivoJournal of Virology, 2004
- Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registryPediatric Pulmonology, 2003
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981